Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and ...

Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...

A big part of Biogen's efforts to defend its spinal muscular atrophy (SMA) business has been dealt a setback by the FDA, which declined to approve a high-dose version of its flagship Spinraza product.

Johnson & Johnson's hopes of quickly building its new cancer drug Rybrevant into a $5 billion product have been undermined by an FDA decision. The US regulator has turned down J&J's marketing ...

Charles River Laboratories (CRL) has delivered a 28.49% change over the past year, with a 52-week range between 91.86 and 228.88. What Is the Average Daily Trading Volume of Charles River Laboratories ...

About Charles River Laboratories International Inc. Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It ...